About this trial
Time processing, the ability to process and encode temporal information, is essential for cognitive functioning and for a large number of daily life activities. In particular, the processing of durations of several seconds is central to cognition, impaired in several pathologies, and has been associated with cognitive changes with advancing age. While behavioral studies have been conducted to specify the neural bases of temporal cognition and their association with other cognitive functions, the mechanisms underlying age-related changes, and individual differences, remain unknown. The project will characterize ageing effects on timing mechanisms and their neural underpinnings. Building on recent advances from neuroscience and age-related cognitive changes, the project focuses on the precision of duration processing, that declines with age, and the associated neural bases. Participants will perform a duration judgement task while (a) electroencephalography, and (b) functional magnetic resonance imaging activity are simultaneously recorded to investigate age effects on structural and functional network connectivity. In addition, striatal dopamine will be measured using a FDOPA PETscan. Evaluation of other temporal cognition processes and general cognition will also be performed. This combination offers a unique opportunity to accurately specifying the neurophysiological underpinning of aging effects on time processing changes. This project will further our understanding of the variability of cognitive performance with advancing age, and contribute to identifying new measures of temporal impairments.
Eligibility criteria
Qualifiers
Membership of a social security scheme or beneficiary of such a scheme.
At least 7 years' schooling.
Acceptance and signature of the informed consent form
Fluency in French (as assessed by the project leader)
Disqualifiers
Persons under guardianship, curators or safeguard of justice.
Pregnant women, women in labor and nursing mothers
Chronic neurological conditions
Uncorrected visual difficulties
Trial design
Treatments tested in this trial
- FDOPA injection before PET imaging
- Time perception tasks
- fMRI imaging
- EEG imaging
- 3 year follow-up